{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:52:57Z","timestamp":1762314777928,"version":"build-2065373602"},"reference-count":32,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000874","name":"Brain and Behavior Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005337","name":"American Academy of Child and Adolescent Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaacap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.jaac.2025.01.024","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T20:06:06Z","timestamp":1738267566000},"page":"550-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Editorial: Placebo Response in Child and Adolescent Psychiatry: To Mitigate or to Harness?"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4373-3293","authenticated-orcid":false,"given":"Manpreet K.","family":"Singh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jaac.2025.01.024_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2352-4642(22)00316-9","article-title":"Comparative efficacy, tolerability, and acceptability of pharmacological interventions for the treatment of children, adolescents, and young adults with Tourette\u2019s syndrome: a systematic review and network meta-analysis","volume":"7","author":"Farhat","year":"2023","journal-title":"Lancet Child Adolesc Health"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.024_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jaac.2024.10.011","article-title":"Systematic review and meta-analysis: placebo response in randomized controlled trials of Tourette\u2019s disorder medications","volume":"64","author":"De Barros","year":"2025","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"10","key":"10.1016\/j.jaac.2025.01.024_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.29397","article-title":"Efficacy and safety of fixed-dose deutetrabenazine in children and adolescents for tics associated with Tourette syndrome: a randomized clinical trial","volume":"4","author":"Coffey","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"10","key":"10.1016\/j.jaac.2025.01.024_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.28204","article-title":"Safety and efficacy of flexible-dose deutetrabenazine in children and adolescents with Tourette syndrome: a randomized clinical trial","volume":"4","author":"Jankovic","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.jaac.2025.01.024_bib5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/jcph.2035","article-title":"Pediatric and adult placebo response rates in placebo-controlled clinical trials submitted to the US Food and Drug Administration 2012-2020","volume":"62","author":"Park","year":"2022","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.024_bib6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00787-018-1244-7","article-title":"Placebo response rates and potential modifiers in double-blind randomized controlled trials of second and newer generation antidepressants for major depressive disorder in children and adolescents: a systematic review and meta-regression analysis","volume":"29","author":"Meister","year":"2020","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.024_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00787-012-0316-3","article-title":"Predictors and moderators of outcome in child and adolescent anxiety and depression: a systematic review of psychological treatment studies","volume":"22","author":"Nilsen","year":"2013","journal-title":"Eur Child Adolesc Psychiatry"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.024_bib8","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s10578-019-00900-w","article-title":"Multi-informant expectancies and treatment outcomes for anxiety in youth","volume":"50","author":"Norris","year":"2019","journal-title":"Child Psychiatry Hum Dev"},{"issue":"8","key":"10.1016\/j.jaac.2025.01.024_bib9","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/j.jaac.2011.04.004","article-title":"Deconstructing pediatric depression trials: an analysis of the effects of expectancy and therapeutic contact","volume":"50","author":"Rutherford","year":"2011","journal-title":"J\u00a0Am Acad Child Adolesc Psychiatry"},{"issue":"7","key":"10.1016\/j.jaac.2025.01.024_bib10","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1176\/appi.ajp.2012.12040474","article-title":"A\u00a0model of placebo response in antidepressant clinical trials","volume":"170","author":"Rutherford","year":"2013","journal-title":"Am J Psychiatry"},{"issue":"6","key":"10.1016\/j.jaac.2025.01.024_bib11","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1136\/medethics-2013-101410","article-title":"The placebo effect in psychiatry: problem or solution?","volume":"40","author":"Huculak","year":"2014","journal-title":"J\u00a0Med Ethics"},{"issue":"9","key":"10.1016\/j.jaac.2025.01.024_bib12","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/1744666X.2018.1516144","article-title":"The role of placebo effects in immune-related conditions: mechanisms and clinical considerations","volume":"14","author":"Smits","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.jaac.2025.01.024_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2147\/PRBM.S439783","article-title":"Would you take an open-label placebo pill or give one to your child? Findings from a cross-sectional survey","volume":"17","author":"Schienle","year":"2024","journal-title":"Psychol Res Behav Manag"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.024_bib14","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/jcph.2160","article-title":"Pediatric efficacy extrapolation in drug development submitted to the US Food and Drug Administration 2015-2020","volume":"63","author":"Samuels","year":"2023","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"8","key":"10.1016\/j.jaac.2025.01.024_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2024.0994","article-title":"Differential outcomes of placebo treatment across 9 psychiatric disorders: a systematic review and meta-analysis","volume":"81","author":"Bschor","year":"2024","journal-title":"JAMA Psychiatry"},{"issue":"10","key":"10.1016\/j.jaac.2025.01.024_bib16","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1089\/cap.2021.0030","article-title":"Meta-analysis: pediatric placebo response in depression trials does not replicate in anxiety and obsessive-compulsive disorder trials","volume":"31","author":"Nasir","year":"2021","journal-title":"J\u00a0Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.jaac.2025.01.024_bib17","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jpsychires.2017.07.018","article-title":"Does the increasing placebo response impact outcomes of adult and pediatric ADHD clinical trials? Data from the US Food and Drug Administration 2000-2009","volume":"94","author":"Khan","year":"2017","journal-title":"J\u00a0Psychiatr Res"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.024_bib18","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/s41380-021-01134-w","article-title":"Placebo and nocebo responses in randomised, controlled trials of medications for ADHD: a systematic review and meta-analysis","volume":"27","author":"Faraone","year":"2022","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.jaac.2025.01.024_bib19","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpsychires.2020.12.040","article-title":"Defining tic severity and tic impairment in Tourette disorder","volume":"133","author":"McGuire","year":"2021","journal-title":"J\u00a0Psychiatr Res"},{"issue":"4","key":"10.1016\/j.jaac.2025.01.024_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/154733251903100404","article-title":"Rising placebo response rates threaten the validity of antipsychotic meta-analyses","volume":"31","author":"Dotson","year":"2019","journal-title":"Ann Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.024_bib21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41386-023-01600-9","article-title":"How should we design future mechanistic and\/or efficacy clinical trials?","volume":"49","author":"Fava","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.jaac.2025.01.024_bib22","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1002\/mdc3.13849","article-title":"Safety and efficacy of long-term deutetrabenazine use in children and adolescents with tics associated with Tourette syndrome: an open-label extension study","volume":"10","author":"Jankovic","year":"2023","journal-title":"Mov Disord Clin Pract"},{"issue":"1","key":"10.1016\/j.jaac.2025.01.024_bib23","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s44159-021-00012-0","article-title":"Platform trials and the future of evaluating therapeutic behavioural interventions","volume":"1","author":"Gold","year":"2022","journal-title":"Nat Rev Psychol"},{"key":"10.1016\/j.jaac.2025.01.024_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2023.101061","article-title":"A\u00a0platform trial approach to proof-of-concept (POC) studies in autism spectrum disorder: Autism Spectrum POC Initiative (ASPI)","volume":"32","author":"Wathen","year":"2023","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/j.jaac.2025.01.024_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102384","article-title":"Current state-of-the-art and gaps in platform trials: 10 things you should know, insights from EU-PEARL","volume":"67","author":"Koenig","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.jaac.2025.01.024_bib26","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.clinph.2021.10.017","article-title":"The Human Tic Detector: an automatic approach to tic characterization using wearable sensors","volume":"134","author":"Cernera","year":"2022","journal-title":"Clin Neurophysiol"},{"issue":"3","key":"10.1016\/j.jaac.2025.01.024_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1176\/appi.ajp.2018.18070857","article-title":"Interrogating the genetic determinants of Tourette\u2019s syndrome and other tic disorders through genome-wide association studies","volume":"176","author":"Yu","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.jaac.2025.01.024_bib28","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.3390\/ijms24021428","article-title":"Molecular landscape of Tourette\u2019s disorder","volume":"24","author":"Widomska","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"5","key":"10.1016\/j.jaac.2025.01.024_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.pupt.2013.01.006","article-title":"Mechanisms of the placebo response","volume":"26","author":"Benedetti","year":"2013","journal-title":"Pulm Pharmacol Ther"},{"issue":"1-3","key":"10.1016\/j.jaac.2025.01.024_bib30","first-page":"19","article-title":"Current and emerging technologies to address the placebo response challenge in CNS clinical trials: promise, pitfalls, and pathways forward","volume":"21","author":"Horan","year":"2024","journal-title":"Innov Clin Neurosci"},{"key":"10.1016\/j.jaac.2025.01.024_bib31","first-page":"1","article-title":"Correlating clinical course with baseline subcortical shape in provisional tic disorder","author":"Che","year":"2024","journal-title":"CNS Spectr"},{"issue":"12","key":"10.1016\/j.jaac.2025.01.024_bib32","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1038\/s41386-020-0762-4","article-title":"Optimizing behavior therapy for youth with Tourette\u2019s disorder","volume":"45","author":"McGuire","year":"2020","journal-title":"Neuropsychopharmacology"}],"container-title":["Journal of the American Academy of Child & Adolescent Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856725000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890856725000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T03:50:18Z","timestamp":1762314618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890856725000541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":32,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0890856725000541"],"URL":"https:\/\/doi.org\/10.1016\/j.jaac.2025.01.024","relation":{},"ISSN":["0890-8567"],"issn-type":[{"type":"print","value":"0890-8567"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Editorial: Placebo Response in Child and Adolescent Psychiatry: To Mitigate or to Harness?","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Child & Adolescent Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2025.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaac.2024.10.011","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a92025 American Academy of Child and Adolescent Psychiatry","name":"copyright","label":"Copyright"}]}}